nach oben

Irish Journal of Medical Science (1971 -)

Erschienen in:

10.02.2021 | COVID-19 | Review Article Zur Zeit gratis

There are similarities between rheumatic disease with lung involvement and COVID-19 pneumonia

verfasst von: Joseph Williamson, Louisa Black, Anna Black, Gouri Koduri, Clive Kelly

Erschienen in: Irish Journal of Medical Science (1971 -) | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Abstract

Introduction

There is considerable overlap between the clinical manifestations of covid-19 pneumonia and the acute interstitial lung disease seen in certain rheumatic disorders. In addition, pulmonary fibrosis is increasingly recognised as a potentially serious consequence of both.

Methods

This review explores this overlap of clinical features, risk factors and causation, offering insights into the immune mechanisms that contribute to both sets of disorders.

Results

The therapeutic role of immunosuppression and biologic agents in the treatment of covid-19 is explained in the light of this.

Discussion

We propose how lessons learned from the insights recently gained into each disorder can improve our insight into immunological mechanisms and application of therapeutic interventions in the other.

Fraser E (2020) Long term respiratory complications of covid-19. BMJ 370:179

George P, Wells A, Jenkins G (2020) Pulmonary fibrosis and Covid-19: the potential role for anti-fibrotic therapy. Lancet Respir Med 8(8):P807-815CrossRef

Raghu G, Wilson K (2020) Covid-19 interstitial pneumonia: monitoring the clinical course in survivors. Lancet Respir Med 8(9):P839-842CrossRef

Das K, Lee E, Al Jawder S et al (2015) Acute Middle East Respiratory Syndrome Coronavirus: temporal lung changes observed on the chest radiographs of 55 patients. Am J Roentgenology 205(3):267–274CrossRef

Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS (2020) Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med 3:1–5

Huang H, Zhang M, Chen C et al (2020) Clinical characteristics of COVID-19 in patients with pre-existing ILD: A retrospective study in a single center in Wuhan, China. J Med Virol jmv.26174

Wu C, Chen X, Cai Y et al (2020) Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan. China, JAMA Intern MedCrossRef

Young BE, Ong SW, Kalimuddin S et al (2020) Epidemiologic features and clinical course of patients infected with SARS‐CoV‐2 in Singapore. JAMA 3

Yang X, Yu Y, Xu J et al (2020) Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centred, retrospective, observational study. Lancet Respir Med. https://doi.org/10.1016/S2213-600(20)30079-5

10.

Zhou F, Yu T, Du R et al (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. https://doi.org/10.1016/S0140-6736(20)30566-3

11.

Mehta P, McAuley DF, Brown M et al (2020) COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395(10229):1033–1034CrossRefPubMedPubMedCentral

12.

Yessayan L, Szamosfalvi B, Napolitano L et al (2020) Treatment of Cytokine Storm in COVID-19 patients with immunomodulatory therapy. ASAIO J 66(10):1079–1083. https://doi.org/10.1097/MAT.0000000000001239

13.

Lassale C, Gaye B, Hamer M et al (2020) Ethnic disparities in hospitalisation for covid-19 in england: the role of socioeconomic factors, mental health, and inflammatory and pro-inflammatory factors in a community-based cohort study

14.

Booth R, Barr C (2020) Black people four times more likely to die from Covid-19 ONS finds. https://www.theguardian.com/world/2020/may/07/black-people-four-times-more-likely-to-die-from-covid-19-ons-finds

15.

Bentley GR (2020) Don’t blame the BAME: Ethnic and structural inequalities in susceptibilities to COVID-19. Am J Hum Biol. 32:e23478. https://doi.org/10.1002/ajhb.23478CrossRefPubMed

16.

Ellinghaus D, Degenhardt F, Bujanda L et al (2020) The ABO blood group locus and a chromosome 3 gene cluster associate with SARS-CoV-2 respiratory failure in an Italian-Spanish genome-wide association analysis. medRxiv. https://doi.org/10.1101/2020.05.31.20114991

17.

Alipio M (2020) Vitamin D supplementation could possibly improve clinical outcomes of patients infected with Coronavirus-2019 (COVID-19). Available at SSRN: https://ssrn.com/abstract=3571484 or https://doi.org/10.2139/ssrn.3571484

18.

Agmon-Levin N, Theodor E, Segal R, Shoenfeld Y (2013) Vitamin D in systemic and organ-specific autoimmune diseases. Clin Rev Allergy Immunol 45(2):256–266. https://doi.org/10.1007/s12016-012-8342-yCrossRefPubMed

19.

Kiran G, Debashish D (2008) Vitamin D and rheumatoid arthritis: is there a link? Int J Rheum Dis 20. https://doi.org/10.1111/j.1756-185X.2008.00385.x

20.

Sherin H, Dalia E, Diab H, Takwa Y (2019) Vitamin D deficiency and pulmonary affection in rheumatoid arthritis. Egyptian J Chest Dis Tuberc 68(4). https://doi.org/10.4103/ejcdt.ejcdt_65_19

21.

Guan SY, Cai HY, Wang P et al (2019) Association between circulating 25-hydroxyvitamin D and systemic lupus erythematosus: A systematic review and meta-analysis. Int J Rheum Dis. https://doi.org/10.1111/1756-185X.13676

22.

Benskin L (2020) A basic review of the preliminary evidence that COVID-19 risk and severity is increased in vitamin d deficiency. Front Public Health 8. https://doi.org/10.3389/fpubh.2020.00513

23.

Bolland MJ, Grey AB, Ames RW et al (2007) The effects of seasonal variation of 25-hydroxyvitamin D and fat mass on a diagnosis of vitamin D sufficiency. Am J ClinNutr 86:959–964

24.

Ayoubkhani D, Khunti K, Nafilyan V et al (2021) Epidemiology of post-COVID syndrome following hospitalisation with coronavirus: a retrospective cohort study. medRxiv preprint. https://doi.org/10.1101/2021.01.15.21249885

25.

Bae S-C, Fraser P, Liang MH (1998) The epidemiology of systemic lupus erythematosus in populations of African ancestry: a critical review of the “prevalence gradient hypothesis.” Arthritis Rheum 41(12):2091–2099CrossRefPubMed

26.

Molokhia M, McKeigue P (2000) Risk for rheumatic disease in relation to ethnicity and admixture. Arthritis Res 2(2):115–125CrossRefPubMedPubMedCentral

27.

Sibanda EN, Chase-Topping M, Pfavayi LT et al (2018) Evidence of a distinct group of Black African patients with systemic lupus erythematosus. BMJ Glob Heal 3(5):e000697CrossRef

28.

Nédélec Y, Sanz J, Baharian G et al (2016) Genetic ancestry and natural selection drive population differences in immune responses to pathogens. Cell 167(3):657-669.e21CrossRefPubMed

29.

De Lorenzis E, Natalello G, Gigante L et al (2020) What can we learn from rapidly progressive interstitial lung disease related to anti-MDA5 dermatomyositis in the management of COVID-19? Autoimmun Rev 19(11):102666CrossRefPubMedPubMedCentral

30.

Megremis S, Walker T, He X et al (2020) Antibodies against immunogenic epitopes with high sequence identity to SARS-CoV-2 in patients with autoimmune dermatomyositis. Ann Rheum Dis. https://doi.org/10.1136/annrheumdis-2020-217522

31.

Santos-Ocampo AS, Mandell BF, Fessler BJ (2000) Alveolar hemorrhage in systemic lupus erythematosus. Chest 118(4):1083–1090CrossRefPubMed

32.

Guan WJ, Ni ZY, Hu Y et al (2020) Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 382:1708–1720. https://doi.org/10.1056/NEJMoa2002032CrossRefPubMed

33.

Argulian E, Sud K, Vogel B et al (2020) Right ventricular dilation in hospitalized patients with COVID-19 infection. JACC Cardiovasc Imag. https://doi.org/10.1016/j.jcmg.2020.05.010

34.

Lax S, Skok K, Zechner P et al (2020) Pulmonary arterial thrombosis in COVID-19 with fatal outcome: Results from a prospective, single-centre clinicopathologic case series. Ann Intern Med

35.

Paranjpe I, Fuster V, Lala A et al (2020) Association of treatment dose anticoagulation with in-hospital survival among hospitalized patients with COVID-19. J Am CollCardiol. https://doi.org/10.1016/j.jacc.2020.05.001CrossRef

36.

Zuo Y, Estes SK, Ali RA et al (2020) Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19. Sci Transl Med 570. https://doi.org/10.1126/scitranslmed.abd3876

37.

McBane R, Roldan V, Niven A et al (2020) Anticoagulation in COVID-19: a systematic review, meta-analysis, and rapid guidance from Mayo Clinic. Mayo ClinProc 95(11):2467–2486CrossRef

38.

Ellman P, Ball RE (1948) Rheumatoid disease with joint and pulmonary manifestations. BMJ 2(4583):816–820CrossRefPubMedPubMedCentral

39.

McDonagh J, Greaves M, Wright AR et al (1994) High resolution computed tomography of the lungs in patients with rheumatoid arthritis and interstitial lung disease. Br J Rheumatol 33: 118–122

40.

Bongartz T, Nannini C, Medina-Velasquez Y et al (2010) Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study. Arthritis Rheum 62(6):1583–1591CrossRefPubMedPubMedCentral

41.

Kelly CA, Nisar M, Arthanari S et al (2020) Rheumatoid arthritis related interstitial lung disease - improving outcomes over 25 years: a large multicentre UK study. Rheumatol (Oxford, England). https://doi.org/10.1093/rheumatology/keaa577

42.

Kelly CA, Saravanan V, Nisar M et al (2014) Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics-a large multicentre UK study. Rheumatol 53: 1676–1682

43.

Kelly CA (2014) Interstitial lung disease in rheumatoid arthritis. Rheumatol 53(suppl_1):i15. https://doi.org/10.1093/rheumatology/keu066.002

44.

Manfredi A, Cassone G, Furini F et al (2020) Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicentre retrospective study. Intern Med J 50(9):1085–1090CrossRefPubMed

45.

Mehta P, Porter J, Chambers R et al (2020) B-cell depletion with rituximab in the COVID-19 pandemic: where do we stand? Lancet Rheumatol 2(10):e589-e590

46.

Liu T, Zhang J, Yang Y et al (2020) The potential role of IL-6 in monitoring severe case of coronavirus disease 2019. medRxiv. https://doi.org/10.1101/2020.03.01.20029769

47.

Xu X, Han M, Li T et al (2020) Effective treatment for severe COVID-19 patients with tocilizumab. ChinaXiv:20200300026

48.

The RECOVERY Collaborative Group (2020) Dexamethasone in hospitalized patients with Covid-19 — preliminary report. N Engl J Med. https://doi.org/10.1056/NEJMoa2021436

49.

Balkhair A, Al-Zakwani I, Al BM et al (2020) Anakinra in hospitalized patients with severe COVID-19 pneumonia requiring oxygen therapy: results of a prospective, open-label, interventional study. Int J Infect Dis 17(103):288–296. https://doi.org/10.1016/j.ijid.2020.11.149CrossRef

50.

Fallet B, Kyburz D, Walker U (2020) Mild course of COVID-19 and spontaneous virus clearance in a patient with depleted peripheral blood B cells due to rituximab treatment. Arthritis Rheumatol 72(9):1581–1582CrossRefPubMed

51.

Tepasse PR, Hafezi W, Lutz M et al (2020) Persisting SARS-CoV-2 viraemia after rituximab therapy: two cases with fatal outcome and a review of the literature. Brit J Haematol 190(2):185–188CrossRef

52.

Gordon A, Mouncey P, Al-Beidh F et al (2020) Interleukin-6 receptor antagonists in critically ill patients with Covid-19 – preliminary report: the REMAP-CAP investigators. medRxiv preprint. https://doi.org/10.1101/2021.01.07.21249390

Titel: There are similarities between rheumatic disease with lung involvement and COVID-19 pneumonia
verfasst von: Joseph Williamson
Louisa Black
Anna Black
Gouri Koduri
Clive Kelly
Publikationsdatum: 10.02.2021
Verlag: Springer International Publishing
Schlagwort: COVID-19
Erschienen in: Irish Journal of Medical Science (1971 -) / Ausgabe 1/2022
Print ISSN: 0021-1265
Elektronische ISSN: 1863-4362
DOI: https://doi.org/10.1007/s11845-021-02545-y

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

There are similarities between rheumatic disease with lung involvement and COVID-19 pneumonia

Abstract

Introduction

Methods

Results

Discussion

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Bei seelischem Stress sind Checkpoint-Hemmer weniger wirksam

Antikörper mobilisiert Neutrophile gegen Krebs

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

Update Innere Medizin

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Introduction

Methods

Results

Discussion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2022

Effects of early intake of amino acid on the neurodevelopmental outcomes in very low birth weight infants at correct age of 20 months and school age

A multidisciplinary fetal neurosurgical service—5 years of fetal outcomes from a national referral centre

Practice and training in radiology in response to the COVID-19 pandemic: a reflection from an Irish academic tertiary referral centre

Development and sustainment of professional relationships within longitudinal integrated clerkships in general practice (LICs): a narrative review

The role of taurine derivatives in the putative therapy of COVID-19-induced inflammation

The correlation between 6-min walk test and respiratory parameters in children with cystic fibrosis

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Bei seelischem Stress sind Checkpoint-Hemmer weniger wirksam

Antikörper mobilisiert Neutrophile gegen Krebs

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

Update Innere Medizin